Search Results for:

Sort by: Relevance Date
121 - 135 of 901 Results

2020 healthcare and life sciences investment outlook

Analysis of the 2020 KPMG Healthcare and Life Sciences Investment Outlook survey sheds light on how the investment landscape will be impacted by influential disruptors, evolving market trends, and policy/regulatory developments.
No Date

Accelerated/advance payment for medicare providers and suppliers

To learn more about enhancements to CMS’s Accelerated & Advance Payment Program to help providers & suppliers during COVID.
No Date

HHS announces additional allocations for CARES Act provider relief funds

HHS has announced plans to distribute the remaining $70 billion in CARES Act relief funds to providers; for more information
No Date

Recent CMS waivers and flexibility

To learn how CMS is offering health systems greater flexibility and critical waivers during the COVID-19 crisis
No Date

Coding for COVID-19

For an overview of how to navigate the new COVID-19 coding guidance, going into effect on April 1, 2020
No Date

Compliance can’t wait

As healthcare providers battle COVID-19, they may need help balancing compliance obligations. For more on what to expect
No Date

Coronavirus Aid, Relief, and Economic Security (CARES) Act

Economic support and stimulus bill
No Date

COVID-19: Telemedicine and tax

As telemedicine accelerates, the need for greater tax clarity and updated guidance relating to virtual healthcare is evident.
No Date

COVID-19: Resilience, recovery and new reality

Helping Healthcare and Life Sciences organizations work together to meet the unprecedented challenges of a rapidly changing landscape.
No Date

The critical role of health plans during and after COVID-19

Health plans are seeking to address economic, workforce and remote member challenges during the COVID-19 outbreak; for more
No Date

The customer experience continuum

Payers must join health systems and pharmaceutical manufacturers in efforts to improve customer experience.
No Date

Diagnostics: Ramp-up of testing for COVID-19 & beyond

Private labs seeking to restructure or build to deploy COVID-19 testing operations can benefit from KPMG’s rapid start-up approach
No Date

Don’t open the door to another threat

Although healthcare organizations are focused on fighting COVID-19, the need for ongoing cyber security should not be underestimated.
No Date

Executive order on ‘Most-Favored-Nation’ drug pricing

An Executive Order directs HHS rulemaking for “most favored nations” pricing for Medicare Part B and D drugs
No Date

Executive orders on prescription drug costs

Four Executive Orders (EO) described as action to deliver lower prescription drug prices to American Patients.
No Date
121 - 135 of 901 Results: